Current Report Filing (8-k)
28 2월 2022 - 10:40PM
Edgar (US Regulatory)
0001510518
false
0001510518
2022-02-23
2022-02-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 23, 2022
GENUFOOD ENERGY ENZYMES CORP.
(Exact name of registrant as specified in charter)
Nevada |
|
000-56112 |
|
68-0681158 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
1108 S. Baldwin Avenue, Suite 107
Arcadia, California |
|
91007 |
(Address of principal executive offices) |
|
(Zip Code) |
(855) 707-2077
Registrant’s telephone number
Not Applicable
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below):
| ☐ | Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered
pursuant to Section 12(b) of the Act: None
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 4.01 Changes in Registrant’s Certifying Accountant.
On February 23, 2022, (i) DYH & Company (“DYH”) resigned
as the independent registered public accounting firm of Genufood Energy Enzymes Corp. (the “Company); and (ii) the Board of Directors
of the Company, which acts as the audit committee, engaged KCCW Accountancy Corp. (“KCCW”) as the Company’s new independent
registered public accounting firm.
The reports of DYH on the consolidated financial statements of the
Company as of and for the years ended September 30, 2020 and 2021 did not contain an adverse opinion or disclaimer of opinion, nor were
they qualified or modified as to uncertainty, audit scope or accounting principle.
During the years ended September 30, 2020 and 2021 and through February
23, 2022, there were no disagreements with DYH on any matter of accounting principles or practices, financial statement disclosure, or
auditing scope or procedure, which disagreements, if not resolved to the satisfaction of DYH, would have caused DYH to make reference
to the subject matter of the disagreement in its reports on the Company’s consolidated financial statements for such years.
The Company has provided DYH with a copy of the disclosures it is making
herein and has requested that DYH furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not
DYH agrees with the above statements. A copy of such letter is filed herewith as Exhibit 16.1.
No consultations occurred between the Company and KCCW during the years
ended September 30, 2020 and 2021 and through February 23, 2022, regarding either (i) the application of accounting principles to a specific
completed or proposed transaction, the type of audit opinion that might be rendered on the Company’s financial statements, or other
written or oral information provided that was an important factor considered by the Company in reaching a decision as to an accounting,
auditing, or financial reporting issue; or (ii) any matter that was either the subject of a disagreement, as that term is defined in Item
304(a)(1)(iv) of Regulation S-K and the related instructions to Item 304 of Regulation S-K, or a “reportable event,” as that
term is defined in Item 304(a)(1)(v) of Regulation S-K.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 28, 2022 |
GENUFOOD ENERGY ENZYMES CORP. |
|
|
|
|
By |
/s/ Wen-Piao Lai |
|
|
Wen Piao-Lai |
|
|
President and Chief Executive Officer |
2
Genufood Energy Enzymes (CE) (USOTC:GFOO)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Genufood Energy Enzymes (CE) (USOTC:GFOO)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
Genufood Energy Enzymes Corporation (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Genufood Energy Enzymes Corp. News Articles